Clinical Trial Update: Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

This randomized Phase 2 trial compares gemcitabine alone to a combination therapy in patients with advanced biliary tract cancer, with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-11-19